Background: A lead-reactive fibrous capsule (FC) identified by ultrasounds as an atrial or ventricular lead thickness of more than 1 mm above the vendor-declared lead diameter (TL) and its local fibrotic attachment to the cardiac wall (FAC) have never been investigated in vivo, so their relationship with post-extraction masses (ghost) is not known. Methods: Intracardiac echocardiography (ICE) was performed twice during the same extraction procedure in 40 consecutive patients: before and immediately after infected lead extraction Results: The ghost detection rate was high: 60% (24/40 patients); ICE could identify both TL and FAC, TL being noted in 25/40 (62%) patients and FAC in 12/40 patients (30%). Both TL and FAC were significantly associ...
Objectives: The goal of this study was to compare transesophageal echocardiography (TEE) and intraca...
Over the last decades, the implementation of new technology in cardiac pacemakers and defibrillators...
Background: The use of cardiac implantable electronic devices (CIEDs) to treat tachy- and bradyarrhy...
Background: A lead-reactive fibrous capsule (FC) identified by ultrasounds as an atrial or ventricul...
AIMS: The number of cardiovascular implantable electronic devices has increased progressively, lead...
ObjectivesWe sought to determine the incidence, diagnostic value and outcome of intracardiac masses ...
Lead pacemaker infection is a complication on the rise. An infected oscillating mass attached to the...
ObjectivesWe sought to determine the incidence, diagnostic value, and outcome of intracardiac masses...
Echogenic material (EM) on non-infected leads in patients with cardiac implantable device is common ...
BACKGROUND: Data on the use of transesophageal echocardiography (TEE) during transvenous lead extrac...
The epidemics of heart failure and an aging population resulted in an exponential rise in the use of...
The extraction of three implanted (18-, 16-, and ten year-old) damaged nonfunctional leads was compl...
Extraction of pacemaker leads represents the optimal therapy in patients with endocarditis involving...
\u3cp\u3eAims: Abandoned leads are often linked to complications during lead extraction, prompting p...
Cardiac implantable electronic devices are the cornerstone of cardiac rhythm management, with a sign...
Objectives: The goal of this study was to compare transesophageal echocardiography (TEE) and intraca...
Over the last decades, the implementation of new technology in cardiac pacemakers and defibrillators...
Background: The use of cardiac implantable electronic devices (CIEDs) to treat tachy- and bradyarrhy...
Background: A lead-reactive fibrous capsule (FC) identified by ultrasounds as an atrial or ventricul...
AIMS: The number of cardiovascular implantable electronic devices has increased progressively, lead...
ObjectivesWe sought to determine the incidence, diagnostic value and outcome of intracardiac masses ...
Lead pacemaker infection is a complication on the rise. An infected oscillating mass attached to the...
ObjectivesWe sought to determine the incidence, diagnostic value, and outcome of intracardiac masses...
Echogenic material (EM) on non-infected leads in patients with cardiac implantable device is common ...
BACKGROUND: Data on the use of transesophageal echocardiography (TEE) during transvenous lead extrac...
The epidemics of heart failure and an aging population resulted in an exponential rise in the use of...
The extraction of three implanted (18-, 16-, and ten year-old) damaged nonfunctional leads was compl...
Extraction of pacemaker leads represents the optimal therapy in patients with endocarditis involving...
\u3cp\u3eAims: Abandoned leads are often linked to complications during lead extraction, prompting p...
Cardiac implantable electronic devices are the cornerstone of cardiac rhythm management, with a sign...
Objectives: The goal of this study was to compare transesophageal echocardiography (TEE) and intraca...
Over the last decades, the implementation of new technology in cardiac pacemakers and defibrillators...
Background: The use of cardiac implantable electronic devices (CIEDs) to treat tachy- and bradyarrhy...